Lv61
2020 积分 2022-07-13 加入
TYK2: an emerging therapeutic target in rheumatic disease
2个月前
已完结
Development of Preclinical Formulations for Toxicology Studies
2个月前
已完结
Nonclinical Drug Administration
2个月前
已完结
Homogeneous multi-payload antibody–drug conjugates
3个月前
已完结
Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now?
5个月前
已完结
Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer
5个月前
已完结
Trop2 and its overexpression in cancers: regulation and clinical/ therapeutic implications
5个月前
已完结
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
5个月前
已完结
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
6个月前
已完结
Principles of Clinical Pharmacology
7个月前
已完结
皖公网安备34019202002308
